🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a phase II trial using a non-myeloablative cyclophosphamide/ fludar...
Status
Completed
Location
Masonic Cancer Center at University of Minnesota
Start Date
2017-03-09
Trial ID
NCT02661035
This study is being conducted in patients with newly diagnosed breast cance...
Status
Completed
Location
Columbia University Irving Medical Center
Start Date
2012-10
Trial ID
NCT01847001
This study Phase 1 clinical trial aimed to evaluate the safety and prelimin...
Status
Not Yet Recruiting
Location
Vinmec Research Institute of Stem Cell and Gene Technology
Start Date
2026-03-15
Trial ID
NCT07472270
Treatments Being Tested
This is a single center, open-label, 3+3 dose escalation, early phase 1 stu...
Status
Recruiting
Location
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Start Date
2024-08-20
Trial ID
NCT06519565
Treatments Being Tested
The goal of this clinical trial is to learn whether tailoring antibiotic an...
Status
Recruiting
Location
University Hospital Brno
Start Date
2025-05-01
Trial ID
NCT07107477
In our study the investigators want to evaluate the effects of EFTs (emotio...
Status
Completed
Location
Benazir Bhutto Hospital Rawalpindi.
Start Date
2013-07
Trial ID
NCT02169856
The goal of this clinical trial is to evaluate the efficacy of proactive im...
Status
Not Yet Recruiting
Location
Seoul National University Hospital
Start Date
2025-06-25
Trial ID
NCT06977594
Unfortunately, some patients with Crohn's disease (CD) fail to respond to t...
Status
Recruiting
Location
Cedars-Sinai Medical Center
Start Date
2019-11-15
Trial ID
NCT04224558
This is a single center, open-label, phase 2 study in elderly (age ≥ 70) su...
Status
Active Not Recruiting
Location
Icahn School of Medicine at Mount Sinai
Start Date
2019-10-24
Trial ID
NCT04052880
Treatments Being Tested
A phase II trial of a reduced intensity conditioned (RIC) allogeneic hemato...
Status
Recruiting
Location
University of Minnesota Masonic Cancer Center
Start Date
2024-06-05
Trial ID
NCT06412497